SCHEMBL6832081

SCHEMBL6832081

COc1c(N2CC(C)NCC2C)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.75
ALDH1A1 P00352 5/20 0.75
HPGD P15428 4/20 0.75
KCNH2 Q12809 4/20 0.75
POLB P06746 3/20 0.75
HSD17B10 Q99714 2/20 0.75
TDP1 Q9NUW8 2/20 0.75
OPRM1 P35372 2/20 0.75
PRKD3 O94806 1/20 0.75
ALOX15 P16050 1/20 0.75
CLK2 P49760 1/20 0.75
CLK4 Q9HAZ1 1/20 0.75
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
LMNA P02545 2/20 0.61
CYP2C19 P33261 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NPSR1 Q6W5P4 1/20 0.55
ATM Q13315 1/20 0.54
GSK3B P49841 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9634956 0.91 ALDH1A1 (0.64) KDM4EALDH1A1HPGDKCNH2POLB
(S)-Gatifloxacin SCHEMBL22592 0.86 KDM4E (1.00) KDM4EALDH1A1HPGDKCNH2POLB
Gatifloxacin SCHEMBL2224369 0.86 KDM4E (1.00) KDM4EALDH1A1HPGDKCNH2POLB
(R)-Gatifloxacin SCHEMBL5670068 0.86 KDM4E (1.00) KDM4EALDH1A1HPGDKCNH2POLB
(S)-Gatifloxacin SCHEMBL30910969 0.86 KDM4E (1.00) KDM4EALDH1A1HPGDKCNH2POLB
SCHEMBL3963299 0.86 KDM4E (0.70) KDM4EALDH1A1HPGDKCNH2POLB
Gatifloxacin SCHEMBL29356306 0.86 KDM4E (1.00) KDM4EALDH1A1HPGDKCNH2POLB
Gatifloxacin SCHEMBL22591 0.86 KDM4E (1.00) KDM4EALDH1A1HPGDKCNH2POLB
(S)-Gatifloxacin SCHEMBL1046589 0.85 KDM4E (0.98) KDM4EALDH1A1HPGDKCNH2POLB
Gatifloxacin SCHEMBL1380256 0.85 KDM4E (0.98) KDM4EALDH1A1HPGDKCNH2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004101547-A1 PURIFICATION METHODS OF GATIFLOXACIN AND A NOVEL FORM OF GATIFLOXACIN HETERO DRUGS LIMITED (IN) 2004-11-25 WO disclosed